CEO since 2011
Education and training: MBA from
Stockholm School of Economics, studies in agronomy at the Swedish University of
Agricultural Sciences in Uppsala
Main experience: Andreas is co-founder of several companies, the most recent being Sigrid Therapeutics AB (obesity therapy) and Atrogi AB (diabetes). Andreas has worked as a management consultant for more than 10 years, specializing in sales and leadership. In addition to the above
companies, he is a co-founder of Kichisaga Leadership (management consultancy) and GenderTimer (cell phone app).
Other assignments: Board member and owner of Vega Bianca AB, deputy board member and co-owner of Kichisaga Leadership AB, as well as co-owner of Atrogi AB and Mailendar AB
Holds 319,310 shares through the company Vega Bianca AB and stock options
entitling to 53,422 shares.
CFO since 2017
Education and training: Master’s degree in Business Administration from Uppsala University
Main experience: Eva has many years of experience from the financial side in larger companies within business controlling, financial controlling, reporting and internal audit. She also has extensive experience from major international groups in areas such as the pharmaceutical industry.
Holds no shares.
CTO since 2012 &
Head of Drug Delivery since 2015
Education and training: Doctorate in
physical chemistry from The Ian Wark
Research Institute at the University of South Australia in Adelaide, Australia
Main experience: Adam has over 15 years’ academic research experience in the area of nanoparticles, biomaterials and medical implants as well as a broad range of analytical methodologies including various
microscopy and spectroscopy techniques. He also has five years’ industrial experience from the Institute for Surface Chemistry (currently SP Chemistry, Materials and
Surfaces) as head of research and business manager in charge of managing contract research serving the food, cosmetics and pharmaceutical industry.
Other assignments: Adam serves as scientific advisor to Sigrid Therapeutics and to SwedNanoTech. He is also adjunct professor at the Royal Institute of Technology (KTH), Stockholm.
Holds 1,000 shares and stock options entitling to 19,372 shares.
COO since 2016
Education and training: Master of Science in Chemical Engineering from Chalmers University of Technology, Gothenburg
Main experience: Nina has more than 15 years’ experience from pharmaceutical
production, mainly within production
management and efficiency (Lean) but also as a project manager for capital projects as well as technology transfer projects. She also has 5 years’ experience from petrochemical production and many years’ experience from large international companies.
Holds stock options entitling to 9,817 shares.
Head of Global Sales, Chromatography
Projects / Accounting
Senior Scientist, Chromatography
Principal Scientist, Chromatography
Business Area Manager, Drug Delivery
Quality Assurance Manager
Scientist, Drug Delivery
Lead Scientist, Drug Delivery